Apomorphine hydrochloride sublingual tablets:a potent dopamine D_2-receptor activation for the treatment of erectile dysfunction
He Zhanju,Jin Jie,Zhang Kai,Mao Yunyi,Bai Jinliang,Wan Jianghou,Deng Jianhua,Zhang Shisheng,Wang Gongxian,Feng Liang,Li Dongshui,Liu Xiuheng,Zhang Xiaobin,Wang Yangmin,Gao Guohui,Yang Luoyan,Liu Tairong,Liao Haiqiu
DOI: https://doi.org/10.3969/j.issn.1008-0848.2009.02.006
2009-01-01
Abstract:Objective To evaluate the efficacy and safety of apomorphine hydrochloride sublingual tablets,a sublingual dopamine D_2-receptor activation,in the treatment of erectile dysfunction.Methods Integrated analyses were made of 8-weeks,randomized,double-blind,placebo-controlled phase 2 clinical trials involving 238 men with mild-to-severe erectile dysfunction of various etiologies who received apomorphine hydrochloride 2 or 3mg(n=158)or placebo (n=80).Results The statistic results of International Index of Erectile Function and Patient Sexual Encounter Profile (SEP)diaries were significantly higher in the apomorphine hydrochloride patients than in the placebo controls.The main drug-related adverse events were dizziness,nausea,flushing,sweat,naupathia and vomit,which were mild and could be self-relieved.Conclusion The apomorphine hydrochloride therapy significantly ameliorated erectile function and was well tolerated by a wide range of patients with erectile dysfunction.